Hemodialysis (HD) is a critical life-supporting intervention for managing end-stage renal disease (ESRD). Despite its significance, this membrane-based therapy presents acute side-effects stemming from bioincompatibility concerns and challenges in effectively eliminating uremic toxins. The current investigation delves into the impact of hydrodynamic conditions employed during HD treatment on the inflammatory and thrombotic responses mediated by proteins.
No takes yet. Share an insight, caveat, or question.
Abdelrasoul et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: